Abstracts tagged "biologic response modifiers and methotrexate (MTX)"

Abstract Number: 2482 • ACR/ARP Annual Meeting 2019
Differences and Similarities According to Gender in Patients with Psoriatic Arthritis Initiating Biological Therapy
Diego Benavent¹, Chamaida Plasencia ², Victoria Navarro-Compán ³, Laura Nuño ⁴, Irene Monjo ⁵, Carolina Tornero ⁶ and Alejandro Balsa ⁷, ¹Hospital Universitario La Paz, Madrid, Spain, ²Immuno-Rheumatology Research Group, IdiPaz & Rheumatology Department. La Paz University Hospital, Madrid, Spain, ³University Hospital La Paz, IdiPaz, Madrid, Spain, ⁴Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, Madrid, Spain, ⁵FIBHULP-IdiPAZ-Hospital La Paz-Rheumatology, Madrid, Spain, ⁶Rheumatology Department. La Paz University Hospital., Madrid, ⁷Hospital Universitario La Paz, Madrid
Background/Purpose: Growing evidence has pointed gender as a key variable influencing clinical response to biological drugs in psoriatic arthritis(PsA). Although the reasons remain unclear, it…